NIH-funded research R01 grant

Metabolic biomarkers to diagnose and predict vaginitis caused by infection

Official title: Next Generation Metabolic Signatures of Infectious Causes of Vaginitis: Small Molecule Metabolite-Based Biomarkers for Diagnosis, Test-of-Cure, and Prediction of Recurrence

Funded at Fred Hutchinson Cancer Center · NIH-11347160 · Data updated 2026-11-12

A new test using small molecule metabolites in vaginal fluid could quickly and cheaply tell if vaginitis is caused by BV, VVC, or trichomoniasis and help predict if it may recur.

More Recurrence research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionFred Hutchinson Cancer Center
NIH-funded
Lab location1 site (Seattle, United States)
Project startJune 3, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$867,869
NIH project number1R01AI198726-01
Project IDNIH-11347160 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are women experiencing vaginal discharge who consent to provide vaginal fluid samples and participate in diagnostic testing.

Less likely to help

Patients with non-infectious causes of discharge or those not meeting enrollment criteria may not benefit.

What this research studies

This project looks at tiny molecules produced by microbes and the body in vaginal fluid to distinguish the common causes of vaginitis. By identifying a set of metabolite signatures, the study aims to create accurate, rapid diagnostic tools that could be used in clinics. If successful, these biomarkers could also help determine whether a treatment has worked and whether the infection might come back. The research involves analyzing samples from women with vaginitis and validating findings against current standard tests.

Why it matters

Potential benefit: If successful, patients could get faster, cheaper and more precise diagnoses and better guidance on treatment and recurrence risk.

How similar studies have gone: Previous work has shown metabolic profiles differ between BV and non-BV conditions, supporting potential diagnostic value but further validation is needed.

Where this research is happening

  • Fred Hutchinson Cancer Center
    Seattle, United States
    Active

Researchers

  • Principal investigator: Srinivasan, Sujatha — Fred Hutchinson Cancer Center
  • Study coordinator: Srinivasan, Sujatha

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.